Waters Xevo TQ-XS system
Waters Xevo TQ-XS system
批准号:
10431349
负责人:
Pawel K Lorkiewicz
金额:
$40.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-15 至 2023-06-14
关键词:
AcetylcysteineAddressAdrenal Cortex HormonesAerosolsAminesAmino AcidsAreaBackBile AcidsBiologicalBiological AssayCardiovascular DiseasesCarnosineCatecholaminesChronicComplementComplexCortisoneDiabetes MellitusDipeptidesEquipmentExerciseFelis catusFundingHumanHydrocortisoneImmunologyIndividualInfrastructureIsoprostanesLaboratoriesLipidsLiquid ChromatographyLiver diseasesMass Spectrum AnalysisMeasurementMeasuresMetabolic DiseasesMethodsMinorObesityPlasmaResearchResearch PersonnelResearch Project GrantsScienceSystemTraining and EducationUnited States National Institutes of HealthUniversitiesVolatile Fatty AcidsWaterWorkXenobioticsadductenvironmental toxicologyhigh throughput screeninginstrumentinstrumentationlipidomicsmass spectrometermeetingsmetabolomicsmethod developmentmicrobialtobacco productsurinaryvolatile organic compound
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
The Bioanalytics Core laboratory at the University of Louisville Diabetes and Obesity Center (DOC) and other
laboratories on campus operate mass spectrometers dedicated to meeting the ever-increasing and complex
needs of NIH-funded investigators. These needs far exceed current capabilities, with major limitations comprising
a lack of ability for ultrasensitive targeted analyses in the areas of exposomics, metabolomics, and lipidomics.
These applications are central to Major and Minor Users, including five NIH-funded centers and twenty-two
individual research projects focusing on environmental toxicology, cardiovascular, hepatic and metabolic
disease, exercise science, and immunology. We propose to add an ultrasensitive, robust Waters Xevo TQ-XS
triple-quadrupole mass spectrometer with the Acquity I-Class Premier ultraperformance liquid chromatography,
which will address the analytical needs of major and minor users by significantly enhancing breadth of analyte
coverage and sensitivity of targeted bioanalyses, currently out of reach with available LC-MS instruments
available at the University Campus. The proposed system will complement current bioanalytical instrumentation,
currently at full capacity, and provide needed hardware to develop and transfer high-throughput, ultrasensitive
targeted methods to cater to the needs of our users. Specifically, we will set up: i) A platform to quantify ultralow-
level xenobiotic adducts with mercapturic acid and carnosine to aid human exposomics studies; ii) A targeted
method for urinary biogenic volatile organic compound metabolites; iii) A workflow for measurement of bile acids;
iv) specific targeted lipidomics assays (major lipid classes, short-chain fatty acids, and isoprostanes
respectively); v) Quantification of corticosteroids, including cortisol and cortisone, as markers of chronic vi) A
targeted assay for catecholamines and their metabolites in plasma; vii) A method to quantify reactive carbonyls
in tobacco product aerosols; viii) quantification of gut microbial amine metabolites; ix) A high-throughput assay
for measuring amino acids and dipeptides in various biological matrices. Proposed work with the instrument
includes detailed training and education in mass spectrometry and method development, which will further
advance research in the Center and maximize the utility of the proposed system. The DOC has the infrastructure
to maintain and support the new equipment backed by the support of the University.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金